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Theileria parasites subvert E2F 
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intracellular pathogens have evolved intricate mechanisms to subvert host cell signaling pathways 
and ensure their own propagation. A lineage of the protozoan parasite genus Theileria infects bovine 
leukocytes and induces their uncontrolled proliferation causing a leukemia-like disease. Given the 
importance of E2F transcription factors in mammalian cell cycle regulation, we investigated the role 
of E2F signaling in Theileria-induced host cell proliferation. Using comparative genomics and surface 
plasmon resonance, we identified parasite-derived peptides that have the sequence-specific ability to 
increase E2F signaling by binding E2F negative regulator Retinoblastoma-1 (RB). Using these peptides 
as a tool to probe host E2F signaling, we show that the disruption of RB complexes ex vivo leads to 
activation of E2F-driven transcription and increased leukocyte proliferation in an infection-dependent 
manner. This result is consistent with existing models and, together, they support a critical role of E2F 
signaling for Theileria-induced host cell proliferation, and its potential direct manipulation by one or 
more parasite proteins.
Theileria parva and Theileria annulata are tick-transmitted, protozoan parasites of cattle that cause hundreds of 
millions of dollars of economic losses every year in large parts of southern Europe, Africa, and southern Asia. 
These pathogens are notable among protozoan parasites in the ability of the schizont life-cycle stage to induce 
cancer-like phenotypes in host leukocytes. Induction of proliferation and dissemination of infected host cells are 
believed to be important aspects of Theileria-induced pathogenesis1,2. Despite a strong host immune response to 
the parasites3, infection can result in the death of a high proportion of infected animals4. While there has been 
considerable research into host signaling pathways affected during infection, so far only one parasite molecule has 
been shown to be involved in Theileria-induced transformation of host leukocytes1. This protein, a prolyl isomer-
ase secreted by T. parva and T. annulata into the leukocyte cytosol, modifies host oncogenic proteins critical for 
host cell transformation5. Notably, the host ortholog of this parasite protein, PIN16, as well as several other host 
genes that are critical for transformation7 are dependent on the activation of the host’s E2F cell-cycle regulators 
and transcription factors. E2F proteins have been previously postulated to be activated during Theileria infection 
through IL-2 and PI3K-dependent PKB/AKT signaling7. More recently, E2F-1, E2F2, and E2F3 were shown to be 
highly expressed, but slightly down-regulated at the transcript level in Theileria-transformed cells compared to 
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uninfected controls8; however, the functional role of E2F signaling in Theileria-induced host cell proliferation has 
not yet been thoroughly characterized.
Here, we leveraged a comparative genomics approach to predict parasite protein sequences that are poten-
tially involved in the Theileria-induced transformation of host leukocytes. We discovered a peptide derived from 
a parasite protein that has the sequence-specific and infection-specific ability to increase host E2F signaling by 
binding to the Retinoblastoma-1 (RB), a negative regulator of E2F signaling, and thereby contributing to host cell 
hyper-proliferation. Hence, cumulative evidence to date demonstrates the critical role of the RB/E2F signaling 
axis in Theileria host cell proliferation, and suggests a mechanism by which one or more parasite proteins could 
manipulate E2F signaling.
Results
We developed a bioinformatics pipeline to perform a comprehensive prediction of potential host-transforming, 
short linear motifs in Theileria proteins. This pipeline was based on the rationale that such peptide motifs have all 
of the following attributes: (i) are in proteins predicted to be exposed to the host (i.e. secreted), (ii) are present in 
host-transforming Theileria species (T. parva and T. annulata), and (iii) are found in proteins that are expressed in the 
schizont life-cycle stage based on RNA-seq data. In order to reduce false positives, we also imposed a strict criterion 
that the protein motif be absent in the protein sequences of orthologs found in other apicomplexan genomes, includ-
ing non-transforming Theileria (T. orientalis and T. equi). While only 400 protein orthologs were unique to T. parva 
and T. annulata, a total of 109 protein motifs, present in these 400 proteins, satisfied the required criteria (Fig. 1a,b; 
Supplementary Dataset). This list is critically dependent on a recently generated T. parva genome annotation, since 
the coding sequences of 101 of these 400 genes were altered in the new annotation (Tretina et al., submitted)9.
Interestingly, we identified 15 T. parva proteins that contain a short linear motif predicted to interact with the 
well-studied host tumor suppressor Retinoblastoma-1 protein (RB) (Fig. 1c, Supplementary Table 1). Along with 
p107 and p130, RB is a pocket family protein that plays a critical role in mammalian cell cycle regulation by inhib-
iting E2F transcription factor activity, an important regulator of cell proliferation and survival10. The central RB 
pocket domain is highly conserved between humans and bovids (Supplementary Fig. 1) and has two significant 
binding sites: a) the interface of the A and B cyclin folds, which binds to the E2F transactivation domain LXXLFD 
motif, and (b) a three-helix cleft of the B cyclin fold, which binds to chromatin-modifying proteins containing an 
LXCXE motif, such as histone deacetylase 1 (HDAC1)10. Out of our 15 predicted T. parva RB-binding proteins, 
eight had the LXCXE motif, and seven had the LXXLFD motif (Supplementary Table 1).
Figure 1. Comparative genomics identified 15 Theileria parasite proteins with the potential to alter host E2F 
signaling, one of which can bind Retinoblastoma-1 pocket domain. (a) A heatmap of orthologous proteins that 
are shared by each pair of apicomplexan parasites used in this study. (b) A heatmap of short eukaryotic linear 
motifs in secreted proteins that are shared by pairs of apicomplexan parasites used in this study. (c) 15 Theileria 
secreted proteins have short linear motifs that are present in the Eukaryotic Linear Motif (ELM) database and 
are predicted to interact with host Retinoblastoma-1 (RB). (d) A kinetic surface plasmon resonance binding 
curve (sensorgram) showing that peptides derived from one of the proteins in (c) binds RB in a sequence-
specific manner, as shown by surface plasmon resonance. (e) Listed are estimated dissociation constants for 
the LXCXE peptide (same as (d)), a full-length Theileria protein containing that peptide (TpMuguga02_00667; 
TpGcpE), as well as for host E2F1, binding to the RB pocket domain.
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Since the proliferation of T. parva-infected host cells is thought to be critical for the pathogenesis of infection, 
we investigated whether synthesized peptides, each 9 to 19 amino acids long and containing these 15 T. parva 
motifs, could bind to RB (Supplementary Table 1). Surface plasmon resonance (SPR) was used to screen these 
peptides for specific RB1 pocket domain-binding activity. Recombinant, purified RB pocket domain was coupled 
to the surface of the sensor chip, and purified peptides were introduced at various concentrations to quantify 
kinetics if response curves indicated a detectable protein-protein interaction. Sequence-scrambled peptides were 
used as negative controls to exclude false-positive signals. This approach led to the discovery of two peptides that 
bind RB in a sequence-specific fashion, one with an LXCXE motif (in TpMuguga_02g00667, TpGcpE, Fig. 1d,e), 
and one with an LXXLFD motif (in TpMuguga_02g02355). SPR kinetics assays revealed that full-length, recom-
binant TpGcpE protein also binds the RB pocket domain with nanomolar affinity (18.7 nM) (Fig. 1e).
The discovery of these peptides led us to investigate the particular RB/E2F signaling components in 
Theileria-infected cells. Eight E2F transcription factor genes have been identified in mammals, which can be 
divided into two groups: activators (E2F-1, E2F-2, E2F-3a), which can bind RB, and repressors (e.g. E2F-3b, E2F-
4, E2F-5), which can bind RB, p107 and p130. The balance between the activator and repressor E2Fs seems to 
be primarily controlled by the phosphorylation status of the associated pocket proteins to which they bind. E2F 
interactions with the Dimerization Partner (DP) ligands are also important for regulating E2F transcription factor 
activity11. We used Western blot to compare the levels of RB family, E2F, and DP-1 protein between T. parva- 
transformed cells that were left untreated with those treated with buparvaquone to kill the parasite and induce 
an arrest in host cell proliferation. By comparing expression levels between the buparvaquone-treated and 
untreated groups, we can determine parasite-dependent changes in the expression levels of these proteins. We 
found that the T. parva-transformed B cell line TpMD409.B2 expresses RB, p130, E2F-1, E2F-3, E2F-4, DP-1 
(Fig. 2a). It is noteworthy that phosphorylated RB (pRB) and p130 migrate faster in parasite-killed TpMD409.
B2 cells than in untreated cells (Fig. 2a). These faster migrating bands likely correspond to hypophosphorylated, 
proliferation-suppressive forms of RB and p130, at 24 h and 48 h after treatment with buparvaquone. Interestingly, 
after 48 h of treatment, but not 24 h, E2F-1 and E2F-3 protein levels decrease, a slower-migrating DP-1 band 
increases, but E2F-4 levels remain unaltered (Fig. 2a). This indicates that, in the presence of live intracellular T. parva 
parasites, host cells express higher E2F-1 and E2F-3 levels, DP-1 has decreased post-translational modifications, 
and RB and p130 are hyper-phosphorylated. Furthermore, the binding of E2F to DNA appears to increase in the 
presence of live parasites, since treatment with the parasiticidal drug buparvaquone over 24 h and 48 h is accom-
panied by an overall decrease in E2F DNA binding activity, as well as by an increase in complexes migrating at 
slow and intermediate speed bound to an E2F-dependent promoter, which likely represent E2F/RB repressor 
complexes (Fig. 2b). Proliferation was also confirmed to be dependent on the parasite by BrdU incorporation of 
untreated and buparvaquone-treated T. parva infected cells (Fig. 2c), as has been shown previously8.
We also found that T. parva-transformed B cells, TpMD409.B2 cells, contain significant levels of E2F tran-
scriptional activity, since cells transfected with an E2F-driven luciferase reporter plasmid (E2F-luc) exhibited a 
200% increase in luciferase activity compared to cells transfected with a plasmid containing a mutated E2F bind-
ing site (mutated) (Fig. 3d). Since no system for genetic manipulation is available yet for intracellular Theileria, 
we instead incubated T. parva- and T. annulata-infected bovine leukocytes (transfected with a luciferase reporter 
regulated from an E2F promoter) with synthesized peptides containing the RB-binding LXCXE motif, or a 
mutated LXNXE negative control, linked to a cell-penetrating peptide. If the LXCXE-containing peptide can 
regulate E2F activity in a sequence-specific manner, we would expect it to increase E2F activity, and that this 
effect would be reduced or abrogated in the mutated LXNXE peptide-treated group. As expected, the LXCXE 
peptide increased E2F activity in T. parva-infected B cells, as well as in T. annulata-infected B cells and mac-
rophages. In contrast, the mutated LXNXE peptide did not show the same reporter activity as the LXCXE peptide 
(Fig. 3b,d,e), providing direct functional evidence that the parasite-derived LXCXE motif can induce E2F activity 
in Theileria-infected leukocytes.
Since the LXCXE peptide can induce E2F activity, we investigated whether it could, on its own, increase 
bovine leukocyte proliferation. To extend our observations to T. annulata-infected leukocytes, we incubated 
T. annulata-infected B cells with WT or mutated LXNXE peptides and counted cell numbers at 24 h and 48 h. 
The addition of these peptides had no effect on cell viability in any of the experimental groups (data not shown). 
Importantly, only the LXCXE peptide induced a significant increase in proliferation of T. annulata-infected B cells 
as well as (to a much lesser extent) of uninfected, but immortalized controls (Fig. 3b). Interestingly, an E2F inhib-
itor (HLM006474) specifically reduced the proliferation of T. annulata-infected TBL20 cells and not uninfected 
BL20 cells (Fig. 3c), an effect that was not dependent on cell death (data not shown). These data demonstrate that 
RB/E2F interactions significantly regulate Theileria-driven host leukocyte proliferation.
In order to map the site of the interaction of the LXCXE motif with the RB pocket domain, we used SPR to 
test the ability of full-length TpGcpE protein to compete with two proteins that have known, well-characterized 
interactions with the RB pocket domain, E2F1 and HDAC1. The RB pocket domain was coupled to the surface of 
the sensor chip, and purified, recombinant, full-length TpGcpE was introduced into the flow channel to bind the 
RB pocket domain to saturation; then either purified, recombinant E2F-1 or HDAC1 was added to the channel 
and the response curve recorded to determine if they competed withTpGcpE binding. We found that E2F-1 does 
not compete with full-length TpGcpE for binding to the RB pocket domain (Fig. 4a,b). However, TpGcpE does 
compete with HDAC1 for RB (Fig. 4c,d), despite a > 4.5-fold higher concentration of the latter, suggesting that 
the full-length TpGcpE can compete with endogenous chromatin-modifying enzymes like HDAC1 for binding 
to the LXCXE-binding cleft of the RB pocket domain. We also found that RB interacts with HDAC1 in uninfected 
cells, and to a lesser extent, in infected cells, as detected by co-immunoprecipitation (Fig. 4b,e,f). This could be 
partially explained by competition of HDAC1 with LXCXE-containing proteins, as total RB and HDAC1 levels 
do not seem to be altered by the presence of T. parva (Fig. 4e).
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Discussion
RB binds and represses E2F transcription factor family proteins in non-proliferating cells, in part by recruiting 
LXCXE motif-containing chromatin modifiers to E2F-dependent promoters. Mitogenic signals lead to an increase 
in cellular cyclin-dependent kinase activity, which phosphorylates RB and thereby inactivates RB-dependent E2F 
repression by dissociating the RB-E2F complex. Interestingly, the RB LXCXE-binding cleft is also critical for 
repressing transcription from the cyclin E and cyclin A promoters. Since cyclin E/A-CDK2 complexes can phos-
phorylate and inactivate RB, this provides an important positive feedback signal for proliferation12. Free E2F pro-
teins form heterodimers with E2F dimerization partner proteins DP-1 or DP-2 to form a functional transcription 
factor that regulates cell proliferation and survival10,13.
While full-length TpGcpE was measured to have very strong binding to host RB by SPR, the 
LXCXE-containing peptide derived from TpGcpE bound with lower affinity than the full-length protein (Fig. 1). 
This is indicative of the growing consensus that although the LXCXE motif can be used to identify potential 
RB-interaction partners, structural studies with both pathogen-derived and mammalian host-derived proteins 
indicate that there are other important determinants of high-affinity interactions with the pocket cleft14. For 
example, out of the eight LXCXE motif-containing peptides testing in this study, only one bound RB. This is 
supported by other studies finding that several proteins that interact with this region of RB do not contain an 
obvious LXCXE motif15,16, suggesting that RB interactions in the LXCXE-binding cleft are more complicated than 
currently understood from structural studies.
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Figure 2. RB/E2F signaling is activated by Theileria parasites. (a) Western blot analysis (left) of E2F-1, E2F-3 E2F-4, 
DP-1, pRB, and p130 expression in TpMD409B.2 cells, either left untreated (−), or treated (+) for 24 h and 48 h with 
buparvaquone (BQ), including band intensity quantification (right). Shown are representatives of three independent 
experiments. (b) E2F DNA binding activity in TpMD409B.2 cells was assayed by EMSA using gP32- labeled double-
stranded oligonucleotide spanning E2F binding sites from the dhfr gene promoter. Left panel, nuclear extracts from 
TpMD409B.2 cells were incubated with γP32-labeled probe in absence or presence of a 100 fold molar excess of 
unlabeled wild type (WT), or mutated (MUT) double-stranded oligonucleotide. Binding reactions were resolved 
by non-denaturing polyacrylamide gel, which was processed afterwards for autoradiography. Right panel, EMSA 
analysis of E2F DNA binding activity in nuclear extracts from untreated, proliferating TpMD409B.2 cells (−) and 
TpMD409B.2 cells treated for 24 and 48 h with the parasiticidal drug buparvaquone (+). Arrows indicate E2F in 
complex with RB family proteins (Complexes) or free E2F protein (Free). (c) Flow cytometric analysis of BrdU 
incorporation and DNA content in TpMD409B.2 cells, either left untreated (control), or treated with buparvaquone 
for 24 h and 48 h. Shown is a representative of three independent experiments.
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While TpGcpE was measured to have very strong binding to host RB by SPR (Fig. 1), immunofluores-
cence imaging with a polyclonal antibody (Supplementary Fig. 2) found very little signal outside of the parasite 
co-localizing with host RB. There can be a few alternative, non-competing explanations for our limited ability 
to detect GcpE in the host cell cytosol: (a) the signal peptide in GcpE is also predicted to contain a motif tar-
geting it to the apicoplast (a chloroplast-like organelle specific of the Apicomplexa), suggesting that only small 
amounts of GcpE remain in the host cell cytosol, and at levels below antibody detection; (b) during host cell 
division the multinucleated macroschizont is partitioned into new daughter host cells and enough GcpE gets 
released into the cytosol to sustain E2F activation; or (c) antagonism of the RB/HDAC1 binding by Theileria 
parasites results from competition with more than one parasite-derived motif, since we identified 15 T. parva 
proteins predicted to interact with RB, where eight had the LXCXE motif and seven had the LXXLFD motif. 
Moreover, SPR demonstrated that the LXCXE motif (in TpMuguga_02g00667, TpGcpE), and the LXXLFD motif 
(in TpMuguga_02g02355) bound the RB pocket domain with nanomolar affinity. Examining all 15 proteins for 
their presence in the host cell cytosol and eventual interaction with RB will be necessary to test hypothesis (c). It 
should also be noted that the parasite marker used for staining the schizont (p104), is secreted by the parasite and 
then subsequently localizes to the parasite surface, suggesting that this staining may illuminate more than just 
the parasite intracellular compartment. However, there is some weak GcpE staining outside of the p104-stained 
regions, indicating that some GcpE may localize to the host nucleus.
Our demonstration that penetrating peptides linked to the LXCXE motif in GcpE can block RB-HDAC1 
binding, activate E2F-driven transcription and promote infected leukocyte proliferation, argues that targeting the 
RB/E2F signaling pathway could lead to novel chemotherapeutics against T. annulata-induced pathogenesis. For 
example, drugs have recently been developed to prevent binding of LXCXE motif-containing HPV E7 protein to 
Figure 3. Sequence-specific disruption of RB/E2F signaling with cell permeating peptides reveals the active 
role of E2F signaling during Theileria infection. (a) TpMD409B.2 cells were transfected with E2F-luc (WT = 
wild-type E2F binding construct), or mutated E2F-luc constructs (labeled ‘mutated’) together with a CMV-
lacZ plasmid to normalize for transfection efficiency. Luciferase and β-galactosidase activities were measured 
24 hrs after transfection. E2F-luc relative luciferase activity normalized to mE2F-luc. Shown is the average 
of 3 independent experiments with standard deviation. BL20 or TBL20 cells were treated with (b) 1μM of 
penetrating peptides (VKKKKIKREIKIYIEEVFTPLVLKCKELK-K(FITC)) containing the TpGcpE LXCXE 
motif, or an LXNXE control (VKKKKIKREIKIYIEEVFTPLVLKNKELK-K(FITC)) or (c) E2F inhibitor or 
DMSO control, and then counted by hemacytometer after the indicated timepoints. Shown is the average of 
3 independent experiments with standard deviation. Then, either (d) virulent Ode T. annulata-transformed 
macrophages, or (e) BL20/TBL20 T. annulata-transformed cells were transfected with E2F-luc plasmid (or 
mutated E2F-luc as in (c)) and incubated for 24 hrs at 37 °C. Then, cells were treated with penetrating peptides 
as in (b) for 2 hrs and luciferase activity was quantified. Data shown are representative of three independent 
experiments done with biological duplicates, with mean + standard deviation (*P-value < 0.05 compared to 
untreated; ‡P-value < 0.05 compared to its respective BL20 control).
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host RB and are selectively cytopathic to HPV-infected cells17. In fact, the E2F inhibitor HLM0006474 was able 
to specifically inhibit the proliferation of T. annulata-infected, but not uninfected bovine B cell lines (Fig. 3c), 
indicating that E2F signaling could be a viable target of chemotherapeutic intervention for this infection. Since 
T. parva and T. annulata bind to their host’s mitotic spindle and divide in synchrony with the host leukocytes18, 
host proliferation is intricately linked to parasite proliferation. This unique mechanism of parasite proliferation 
also provides the parasite with immune protection, as it avoids parasite egress from the host cell and exposure to 
the host immune response. We have established that uncontrolled proliferation of Theileria-transformed leuko-
cytes can be achieved through modulation of RB/E2F signaling, and that TpGcpE has the potential to alter those 
interactions. Conclusive demonstration that specific Theileria proteins manipulate host RB/E2F signaling in vivo 
awaits future studies.
Methods
Bioinformatic analyses. Comparative genomics. Jaccard-filtered eukaryotic clusters of orthologous genes 
(KOGs) were generated as described previously19, using the following genomes from EuPathDB (August 25th, 
2014)20: Babesia bovis T2Bo, Cryptosporidium hominis TU502, Cryptosporidium muris RN66, Cryptosporidium 
parvu, Iowa II, Neospora caninnum Liverpool, Plasmodium falciparum 3D7, Plasmodium knowlesi strain H, 
Plasmodium vivax Sal-1, Theileria annulata strain Ankara, Theileria equi strain WA, and Theileria orientalis strain 
Shintoku. Also used for creating the KOGs were the updated Theileria parva strain Muguga annotation and an 
updated Babesia microti RI annotation recently completed by our group21. Localization predictions were made 
with TargetP22, transmembrane domain predictions with TMHMM23, GPI predictions were made with GPI-
SOM24, all using the default parameters. The entire ELM database was downloaded from http://elm.eu.org/ and 
custom scripts were used to search the proteome of each Apicomplexan in the Sybil database using regular expres-
sions in Python and a p-value cutoff of 0.001.
Surface plasmon resonance experiments. Immobilization of human RB1 protein to CM5 chip. Surface 
preparation. Binding reactions were done in HBS-EP buffer from Biacore (Biacore Inc., New Jersey), contain-
ing 10 mM Hepes, 150 mM NaCl, 3 mM EDTA, and 0.05% (v/v) surfactant p20, pH 7.4, filtered (0.2 µM) and 
degassed before use. Protein human Retinoblastoma-1 (LDBiopharma HTF-1035) was created on the surface of 
a BIAcore CM5 sensor chips by direct immobilization. The carboxymethyl-dextran surface of the chip (flow cell 
2, 3 and 4) were activated with a 35 µl injection of a mixture of 0.1 M NHS and 0.1 M EDC in water. An aliquot 
of 100 µl of 10 µg/ml dilution of human Retinoblastoma-1 protein in 10 mM sodium acetate, pH 4.5 was injected 
into flow cell-2 of CM5 chip to get the levels of 2000 resonance units (RU) for the immobilization. The remaining 
Figure 4. An LXCXE motif-containing protein disrupts RB interactions with negative epigenetic regulators 
of E2F signaling, but not RB-E2F interactions. (a) A kinetic surface plasmon resonance binding curve 
(sensorgram) of full-length HDAC1 to the RB pocket domain is shown. (b) Kinetic binding curve of full-
length HDAC1 in competition with full-length TpMuguga02_00667 (TpGcpE). (c) A sensorgram of full-length 
E2F1 to the RB pocket domain is shown. (d) Kinetic binding curve of full-length E2F1 in competition with 
full-length TpMuguga02_00667. (e) Western blot analysis of RB and HDAC1 in BL20 and TBL20 cells. (f) 
Co-immunoprecipitation of RB and HDAC1 in RB immunoprecipitates. Shown is a representative of three 
independent experiments.
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NHS-ester active sites in the dextran surface flow cell-2 was blocked with 35 µl of 1 M ethanolamine, pH 8.2 and 
washed at a high flow rate, 100 µl per minute, with one pulse of 100 µl of HBS-P buffer, pH 7.4. The flow cell-1 of 
same CM5 chip was used as reference (activated with a 35 µl injection of a mixture of 0.1 M NHS and 0.1 M EDC 
in water and blocked with 35 µl of 1 M ethanolamine, pH 8.2).
Kinetics analysis of binding. To minimize mass transport effects, the binding analyses were performed at flow 
rate of 30 µl per minute at 25 °C. The analytes (60 µl each, 0–25 µM in HBS-EP buffer with 0.05% P20) were 
injected into flow cell and the association of analyte and ligand were recorded respectively by surface plasmon 
resonance (SPR) with a Biacore T200 (Biacore, Inc., New Jersey). After this, the surface was washed with buffer 
for 180 seconds to follow the dissociation of analyte-ligand complexes. The signal from the blank channel (flow 
cell-1) was subtracted from the channel containing human Retinoblastoma-1 protein. The binding was removed 
by injecting 100 µl of HBS-P, pH 7.4.
Data analysis. Sensorgrams of the interaction generated by the instrument were analyzed using the software 
BIAeval 3.2 (Biacore Inc., New Jersey). The reference surface data were subtracted from the reaction surface 
data to eliminate refractive-index changes of the solution, injection noise and non-specific binding to the blank 
surface. A blank injection with buffer alone was subtracted from the resulting reaction surface data. Data was 
globally fitted to the steady state affinity.
Cell culture and transient transfections. The TpMD409.B2 cell line is a T. parva Muguga-infected B-cell 
clone (B2) whose establishment, phenotypic characteristics and culture conditions have been described25–27. BL20 
cells are a retrovirus-transformed B cell line isolated from an infected cow. To eliminate the parasite, cells were 
treated for the indicated time with buparvaquone (50 ng/ml, 1 mg/ml stock in ethanol; Sigma). To inhibit E2F 
activity, cells were treated for the indicated time with HLM006474 (10 μM in DMSO, Sigma), or DMSO (10μM; 
Sigma) as a control. The T. annulata-infected cell lines BL20 (B cell), as well as Ode (macrophage) cell lines are 
well described and characterized.
Reporter gene assays. TpMD409.B2 cells were co-transfected with 20 μg (E2F-luc, mE2F-luc), or 10 μg 
(cyclin E-luc) reporter construct, 20 μg of expression vector and 5 μg of pCMV-lacZ, where indicated. Luciferase 
and β-galactosidase activities were measured 24 h after transfection according to previously published proce-
dures25. TpMD409.B2 cells were also co-transfected with pCMV-HA-DP-1 D103–126 and c-myc-luciferase as 
previously described28.
Flow cytometric analysis of BrdU incorporation. TpMD409.B2 cells were transfected as described for 
cell cycle analysis except that H2B-EGFP expression vector (10 μg) was used instead of phGFP-S65T. 48 h after 
transfection, cells were pulse labeled for 1 h with BrdU (5-bromo-2′-deoxyuridine) (10 μg/ml) then harvested 
and fixed in 1% paraformaldehyde, 0.01% Tween 20 for 48 h to 72 h at 4 °C. BrdU staining was performed using 
phycoerythrin-labeled anti-BrdU antibody (Pharmingen) according to the previously published DNase I pro-
cedure29. A minimum of 2,000 events in each whole population and GFP positive fraction were collected on a 
FACSCAN flow cytometer and analyzed with CellQuest.
Alternatively, untreated and buparvaquone treated TpMD409.B2 cells, pulse labeled for 30 min with 
BrdU, were fixed in 70% ethanol overnight at −20 °C. BrdU staining was performed using fluorescein 
isothiocyanate-labeled anti BrdU antibody (Boehringer Mannheim) following the acid denaturation procedure. 
DNA was counter-stained for 30 min at room temperature with propidium iodide (5 μg/ml) in PBS containing 
RNase (200 μg/ml). 10,000 events were analyzed on a FACSCAN.
Cells extracts, antibody and Western Blot analysis. TpMD409.B2 cells were washed twice in ice-cold PBS 
then lysed in ice-cold lysis buffer consisting of 10 mM HEPES pH 8, 150 mM NaCl, 1% NP40, 0.5% sodium deoxy-
cholate, 0.1% SDS to which proteases (Complete, Roche) and phosphatases (5 mM Na3VO4, 50 mM NaF) inhibitors 
were added. Cell debris was pelleted by centrifugation at 13,000xg for 10 min at 4 °C and proteins were quantified by 
the Bradford method. Equal amounts of proteins were resolved by SDS-polyacrylamide gel and electro-transferred to 
nitrocellulose. The following antibodies were used in Western Blot analysis: anti-RB (1:1000) and anti-DP-1 (TFD10) 
(1:500) from Pharmingen, anti-p130 (C-20) (1:400), anti-E2F-1 (KH95) (1:500), anti-E2F-3 (C1–18) (1:1000) and 
anti-E2F-4 (C-108) (1:300) from Santa Cruz Biotechnology. For the generation of antibodies, recombinant TaGcpE 
protein was generated using a pGEX6P-1 plasmid that places a GST-tag at the N-terminal end of the expressed recom-
binant protein. Fragments encoding both the N-terminus (17–412 aa) and C-terminus (413–808 aa) of TaGcpE were 
amplified from cDNA of T. annulata and cloned into the pGEX6p-1 plasmid. The 2 recombinant TaGcpE proteins 
were expressed in BL21 CodonPlus (DE3)-RIPL and cell pellets were suspended in PBS supplemented with protease 
inhibitor, 1 mM EDTA, 1 mg/ml lysozyme, then sonicated and centrifuge 10,000 rpm for 1 h at 4 °C. Cell lysates were 
incubated with glutathione sepharose beads, and recombinant proteins were eluted by elution buffer (10 mM glu-
tathione, 50 mM Tris-HCl pH 8.0). Since the N-terminal half of TaGcpE was not soluble, sera were raised against the 
soluble C-terminal half of TaGcpE by immunizing two rats according to “the Speedy 28-day protocol” (Eurogentec).
Immunofluorescence assays. 5 × 104 cells were plated on glass coverslips coated with poly-L-lysine. Cells 
were fixed with 4% paraformaldehyde in PBS for 10 min, and permeabilized using 0.5% Triton X-100. After a 
30 min treatment with blocking solution (1% BSA and PBST buffer: 0.1% Tween20), cells were stained for 2 h with 
the primary antibodies (anti-RB: Santa Cruz Biotechnology #sc-73598, anti-1C12, and a rat anti-GcpE antibody. 
After three washes with PBS, cells were incubated with the secondary antibody (Alexa fluor 488 donkey anti-rat 
IgG #A21208 and Alexa fluor 594 goat anti-mouse IgG #A11005) for 45 min in the dark. After three additional 
washes, slides were stained with 4–6-diamidino-2-phenylindole, diluted 1/1000 (Sigma Aldrich) for 5 min to 
visualize the nuclei. Labelled preparations were mounted in Dako and analysed by inverted microscopy (Leica 
DMI6000s). Acquisitions were made with the Metamorphous software.
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Electrophoretic mobility shift assay (EMSA). Nuclear extracts were prepared as described previously30. 
5 μg of nuclear extracts were incubated for 30 min at room temperature with gP32 labeled double stranded oligo-
nucleotide in binding buffer (5 mM HEPES Ph 8, 0.5 mM EDTA, 5% glycerol, 0.5 mM DTT, 0.5 M PMSF, 0.5 mM 
MgCl2, 0.005% NP40, 1 mg/ml BSA, sonicated salmon sperm DNA 100 μg/ml). The complexes were resolved on 
a non-denaturing 4% polyacrylamide gel. The following oligonucleotides were used:
E2F – WT: 5′ CTAGTGCAATTTCGCGCCAAACTTG 3′
E2F – MUT: 5′ CTAGTGCAATTGCTCGACCAACTTG 3′
Peptide synthesis. The amino acid sequence of RB-1 based on the parasite sequence (VKKKKIKREIKIYIEEVFTP 
LVLKCKELK) was synthesized. Cysteine in wild type RB1 was replaced by an Asparagine (N; in bold VKKKKIKREIKI 
YIEEVFTPLVLKNKELK). The penetrating peptide to facilitate cell entry is underlined. 3 different concentrations 
of peptides were used for 2 h to determine the minimum effective concentration (1 μM) with minimum toxic 
effect, which was used to perform each experiment as indicated.
Statistical analysis. Student’s two-tailed T-tests were performed for cell culturing experiments with at least 
N = 3 for each experiment. Sample size was chosen based on literature references for similar experiments in other 
systems. The values for N, P, and the specific statistical test performed for each experiment are included in the 
appropriate figure legends or main text. In each figure or text, the following symbols represent respective p-value 
ranges: *0.05 > p ≥ 0.01; **0.01 > p ≥ 0.001, ***p < 0.001. Differences were considered significant if p < 0.05.
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